Bitcoin price today: gains to $120k, near record high on U.S. regulatory cheer
Jay Matushak, the Chief Financial Officer of NeueHealth, Inc. (NASDAQ:NEUE), recently sold shares of the company’s common stock, according to a recent SEC filing. On March 7, Matushak sold 1,860 shares at prices ranging from $7.10 to $7.25 per share, totaling $13,375. Additionally, on March 10, he sold another 184 shares at prices between $6.90 and $7.18, amounting to $1,297. These transactions were conducted to cover tax withholding obligations upon the vesting of restricted stock units, as noted in the filing. Following these sales, Matushak’s direct ownership stands at 24,487 shares.
The micro-cap healthcare company, currently valued at approximately $57 million, has shown strong momentum with a 27% price gain over the past six months. According to InvestingPro analysis, the stock appears undervalued despite its recent performance, with a GOOD Financial Health Score of 2.51. Investors tracking NEUE should note the company’s upcoming earnings report on March 20, 2025. InvestingPro subscribers have access to 12 additional investment tips and comprehensive analysis tools for informed decision-making.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.